ArticleTropical medicine and health2025
Clinical and epidemiological characteristics of the dengue outbreak of 2024: a multicenter observation from Bangladesh.
Article in Tropical medicine and health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Acute-phase clinical profile and quality of life in patients with chikungunya during the 2025 outbreak in Bangladesh: A facility-based cross-sectional study.PLoS neglected tropical diseases · 2026Article
- Clinical and epidemiological characteristics of the 2025 dengue outbreak in Bangladesh.PLoS neglected tropical diseases · 2026Observational
- Progression of dengue during an outbreak (2024) in Dhaka, Bangladesh: a hospital based longitudinal study.The Lancet regional health. Southeast Asia · 2026Article
- Clinical and haematological correlates of severe dengue using 2023 epidemic data: A multicentre tertiary hospital-based analysis from Dhaka, Bangladesh.PLoS neglected tropical diseases · 2026Article
- Article
- Health-related quality of life and associated factors among hospitalized dengue patients in Bangladesh: a cross-sectional study.BMC infectious diseases · 2026Observational
- Insights and implications of a dynamical systems approach to dengue transmission and epidemic behaviour.Scientific reports · 2026Article
- Harnessing a Surface Water-Based Multifaceted Approach to Combat Zoonotic Viruses: A Rural Perspective from Bangladesh and China.Microorganisms · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDengue fever remains a significant public health challenge in Bangladesh. This study aimed to characterize the clinical and epidemiological profiles of confirmed dengue cases during the 2024 outbreak in Bangladesh.
methodsThis observational study was conducted from June to September 2024 in four tertiary care hospitals across Bangladesh located in four administrative divisions. A total of 401 laboratory-confirmed (NS1- or IgM-positive) dengue patients aged ≥ 12 years were included. Demographic data, clinical presentations, and laboratory findings were collected through face‒to-face interviews. The revised WHO 2009 dengue case classification was used for severity assessment of dengue patients. Descriptive and inferential statistics were used to summarize the results.
resultsThe mean age of patients with dengue fever was 29.81 ± 11.64 (SD) years, with 7.2% of the patients being adolescents (aged 12-17 years). A clear male predominance (88.3%) was observed. Overall, 65.6% of patients had dengue with warning signs, and 9% had severe dengue. Fever (94.3%), headache (70.3%), myalgia (66.1%), and gastrointestinal symptoms such as nausea (49.9%) and abdominal pain (43.9%) were common symptoms. The median in-hospital stay of both non-severe and severe cases were 4 & 5 days, respectively. The in-hospital mortality rate was 0.75%, which was significantly higher among severe dengue patients (5.6%).
conclusionThe 2024 dengue outbreak in Bangladesh predominantly affected young adult males, with a notable prevalence of gastrointestinal symptoms alongside classic dengue manifestations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.